An artificial intelligence summit in New Delhi was overshadowed this week after a private Indian university was asked to remove its exhibition booth over claims surrounding a robotic dog that was later identified as a commercially available Chinese product. The incident unfolded at
China’s industrial landscape is undergoing a structural transformation as robotics adoption accelerates across manufacturing, logistics, and heavy industry. What was once concentrated in automotive assembly lines has expanded into electronics, metals processing, warehousing, and even food production. The scale of deployment reflects more
China’s accelerating biotechnology expansion is driving an unexpected cost surge in one of the industry’s most critical research resources, laboratory monkeys used in preclinical drug testing. Prices for experimental monkeys have climbed to around 140,000 yuan per animal, a level that now exceeds
Chinese robotics companies are experiencing a sharp rise in orders after humanoid machines took center stage during this year’s Spring Festival Gala, one of the country’s most-watched annual broadcasts. The televised event, which draws hundreds of millions of viewers across China and abroad,
China based Unitree Robotics is aiming to scale production of its humanoid robots to as many as 20000 units in 2026, marking a sharp increase from roughly 5500 units shipped in 2025. The ambitious target follows the company’s high visibility appearance at China’s
China’s leading humanoid robotics companies stepped into the national spotlight during this year’s Spring Festival Gala, the annual television spectacle broadcast by state media that reaches hundreds of millions of viewers across the country. Their prominent appearance signalled how robotics is moving from
China’s manufacturing sector is entering a new phase of automation in 2026 as robotics adoption accelerates across key industrial clusters. After years of steady deployment, the scale and sophistication of robotic systems now signal a broader productivity cycle rather than isolated factory upgrades.
China’s biotechnology sector is on track for another record year in licensing activity as global pharmaceutical companies intensify their search for innovative drug candidates to offset looming patent expirations and rising research costs. Data from industry tracker Pharmcube shows that out licensing deals
Humanoid robots built by Chinese manufacturers are drawing enthusiastic crowds in San Francisco, where technology startups are staging virtual reality controlled boxing matches that blend entertainment with advanced robotics. At a recent event in the Bay Area, spectators filled a small venue to
A leading Swiss robotics expert has highlighted China’s growing strength in scaling robotics and physical artificial intelligence, pointing to the country’s integrated industrial ecosystem and rapid deployment capabilities as key competitive advantages in the global AI race. Dominic Gorecky, co founder and director
